Research studies validate the role of NOTCH1 in tumor cell proliferation and immune evasion mechanisms in head and neck cancers while demonstrating that increased expression levels are predicted at higher stages and have poor clinical outcomes [15]. This evidence concerns the gene NOTCH1 and head and neck cancer.